Chemoinformaics analysis of OCTADECATETRAENOIC-ACID
| Molecular Weight | 276.42 | nRot | 12 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 5 |
| Exact Molecular Weight | 276.209 | nRing | 0 |
| Solubility: LogS | -4.553 | nHRing | 0 |
| Solubility: LogP | 6.138 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 50.3342 |
| nHD | 1 | BPOL | 28.9578 |
| QED | 0.293 |
| Synth | 2.668 |
| Natural Product Likeliness | 1.374 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.041 |
| HIA | 0.007 |
| CACO-2 | -4.785 |
| MDCK | 0.0000231 |
| BBB | 0.652 |
| PPB | 0.982795 |
| VDSS | 0.561 |
| FU | 0.0163702 |
| CYP1A2-inh | 0.136 |
| CYP1A2-sub | 0.58 |
| CYP2c19-inh | 0.048 |
| CYP2c19-sub | 0.498 |
| CYP2c9-inh | 0.159 |
| CYP2c9-sub | 0.835 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.348 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.115 |
| CL | 0.752 |
| T12 | 0.394 |
| hERG | 0.227 |
| Ames | 0.688 |
| ROA | 0.804 |
| SkinSen | 0.99 |
| Carcinogencity | 0.208 |
| EI | 0.967 |
| Respiratory | 0.807 |
| NR-Aromatase | 0.442 |
| Antiviral | Yes |
| Prediction | 0.610185 |